Selected research
Industry Growth & Trends
Global Antitussive Drugs Industry Growth and Trends Forecast to 2032
Market perspective
The global Antitussive Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Antitussive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Antitussive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Antitussive Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Antitussive Drugs include Alkem Laboratories, Cipla, Glenmark Pharmaceuticals, Toray Industries, Zydus Cadila, AstraZeneca, Pfizer, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Antitussive Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Antitussive Drugs market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antitussive Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antitussive Drugs.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Antitussive Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Antitussive Drugs Market by Company
Alkem Laboratories
Cipla
Glenmark Pharmaceuticals
Toray Industries
Zydus Cadila
AstraZeneca
Pfizer
Merck
Novartis
Johnson & Johnson
Sanofi
Antitussive Drugs Segment by Type
Centrally Acting Antitussive Drugs
Locally Acting Antitussive Drugs
Antitussive Drugs Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Antitussive Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antitussive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antitussive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antitussive Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antitussive Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Antitussive Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Centrally Acting Antitussive Drugs
- Locally Acting Antitussive Drugs
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Alkem Laboratories
- Cipla
- Glenmark Pharmaceuticals
- Toray Industries
- Zydus Cadila
- AstraZeneca
- Pfizer
- Merck
- Novartis
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Antitussive Drugs Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Antitussive Drugs Sales Estimates and Forecasts (2021-2032)
- 1.3 Antitussive Drugs Market by Type
- 1.3.1 Centrally Acting Antitussive Drugs
- 1.3.2 Locally Acting Antitussive Drugs
- 1.4 Global Antitussive Drugs Market Size by Type
- 1.4.1 Global Antitussive Drugs Market Size Overview by Type (2021-2032)
- 1.4.2 Global Antitussive Drugs Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Antitussive Drugs Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Antitussive Drugs Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Antitussive Drugs Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Antitussive Drugs Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Antitussive Drugs Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Antitussive Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Antitussive Drugs Industry Trends
- 2.2 Antitussive Drugs Industry Drivers
- 2.3 Antitussive Drugs Industry Opportunities and Challenges
- 2.4 Antitussive Drugs Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Antitussive Drugs Revenue (2021-2026)
- 3.2 Global Top Players by Antitussive Drugs Sales (2021-2026)
- 3.3 Global Top Players by Antitussive Drugs Price (2021-2026)
- 3.4 Global Antitussive Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Antitussive Drugs Major Company Production Sites & Headquarters
- 3.6 Global Antitussive Drugs Company, Product Type & Application
- 3.7 Global Antitussive Drugs Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Antitussive Drugs Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Antitussive Drugs Players Market Share by Revenue in 2025
- 3.8.3 2025 Antitussive Drugs Tier 1, Tier 2, and Tier 3
4 Antitussive Drugs Regional Status and Outlook
- 4.1 Global Antitussive Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Antitussive Drugs Historic Market Size by Region
- 4.2.1 Global Antitussive Drugs Sales in Volume by Region (2021-2026)
- 4.2.2 Global Antitussive Drugs Sales in Value by Region (2021-2026)
- 4.2.3 Global Antitussive Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Antitussive Drugs Forecasted Market Size by Region
- 4.3.1 Global Antitussive Drugs Sales in Volume by Region (2027-2032)
- 4.3.2 Global Antitussive Drugs Sales in Value by Region (2027-2032)
- 4.3.3 Global Antitussive Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antitussive Drugs by Application
- 5.1 Antitussive Drugs Market by Application
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Antitussive Drugs Market Size by Application
- 5.2.1 Global Antitussive Drugs Market Size Overview by Application (2021-2032)
- 5.2.2 Global Antitussive Drugs Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Antitussive Drugs Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Antitussive Drugs Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Antitussive Drugs Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Antitussive Drugs Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Antitussive Drugs Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Antitussive Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Alkem Laboratories
- 6.1.1 Alkem Laboratories Company Information
- 6.1.2 Alkem Laboratories Business Overview
- 6.1.3 Alkem Laboratories Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Alkem Laboratories Antitussive Drugs Product Portfolio
- 6.1.5 Alkem Laboratories Recent Developments
- 6.2 Cipla
- 6.2.1 Cipla Company Information
- 6.2.2 Cipla Business Overview
- 6.2.3 Cipla Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Cipla Antitussive Drugs Product Portfolio
- 6.2.5 Cipla Recent Developments
- 6.3 Glenmark Pharmaceuticals
- 6.3.1 Glenmark Pharmaceuticals Company Information
- 6.3.2 Glenmark Pharmaceuticals Business Overview
- 6.3.3 Glenmark Pharmaceuticals Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Glenmark Pharmaceuticals Antitussive Drugs Product Portfolio
- 6.3.5 Glenmark Pharmaceuticals Recent Developments
- 6.4 Toray Industries
- 6.4.1 Toray Industries Company Information
- 6.4.2 Toray Industries Business Overview
- 6.4.3 Toray Industries Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Toray Industries Antitussive Drugs Product Portfolio
- 6.4.5 Toray Industries Recent Developments
- 6.5 Zydus Cadila
- 6.5.1 Zydus Cadila Company Information
- 6.5.2 Zydus Cadila Business Overview
- 6.5.3 Zydus Cadila Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Zydus Cadila Antitussive Drugs Product Portfolio
- 6.5.5 Zydus Cadila Recent Developments
- 6.6 AstraZeneca
- 6.6.1 AstraZeneca Company Information
- 6.6.2 AstraZeneca Business Overview
- 6.6.3 AstraZeneca Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 AstraZeneca Antitussive Drugs Product Portfolio
- 6.6.5 AstraZeneca Recent Developments
- 6.7 Pfizer
- 6.7.1 Pfizer Company Information
- 6.7.2 Pfizer Business Overview
- 6.7.3 Pfizer Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Pfizer Antitussive Drugs Product Portfolio
- 6.7.5 Pfizer Recent Developments
- 6.8 Merck
- 6.8.1 Merck Company Information
- 6.8.2 Merck Business Overview
- 6.8.3 Merck Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Merck Antitussive Drugs Product Portfolio
- 6.8.5 Merck Recent Developments
- 6.9 Novartis
- 6.9.1 Novartis Company Information
- 6.9.2 Novartis Business Overview
- 6.9.3 Novartis Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Novartis Antitussive Drugs Product Portfolio
- 6.9.5 Novartis Recent Developments
- 6.10 Johnson & Johnson
- 6.10.1 Johnson & Johnson Company Information
- 6.10.2 Johnson & Johnson Business Overview
- 6.10.3 Johnson & Johnson Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Johnson & Johnson Antitussive Drugs Product Portfolio
- 6.10.5 Johnson & Johnson Recent Developments
- 6.11 Sanofi
- 6.11.1 Sanofi Company Information
- 6.11.2 Sanofi Business Overview
- 6.11.3 Sanofi Antitussive Drugs Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sanofi Antitussive Drugs Product Portfolio
- 6.11.5 Sanofi Recent Developments
7 North America by Country
- 7.1 North America Antitussive Drugs Sales by Country
- 7.1.1 North America Antitussive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Antitussive Drugs Sales by Country (2021-2026)
- 7.1.3 North America Antitussive Drugs Sales Forecast by Country (2027-2032)
- 7.2 North America Antitussive Drugs Market Size by Country
- 7.2.1 North America Antitussive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Antitussive Drugs Market Size by Country (2021-2026)
- 7.2.3 North America Antitussive Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Antitussive Drugs Sales by Country
- 8.1.1 Europe Antitussive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Antitussive Drugs Sales by Country (2021-2026)
- 8.1.3 Europe Antitussive Drugs Sales Forecast by Country (2027-2032)
- 8.2 Europe Antitussive Drugs Market Size by Country
- 8.2.1 Europe Antitussive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Antitussive Drugs Market Size by Country (2021-2026)
- 8.2.3 Europe Antitussive Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Antitussive Drugs Sales by Country
- 9.1.1 Asia-Pacific Antitussive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Antitussive Drugs Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Antitussive Drugs Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Antitussive Drugs Market Size by Country
- 9.2.1 Asia-Pacific Antitussive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Antitussive Drugs Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Antitussive Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Antitussive Drugs Sales by Country
- 10.1.1 South America Antitussive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Antitussive Drugs Sales by Country (2021-2026)
- 10.1.3 South America Antitussive Drugs Sales Forecast by Country (2027-2032)
- 10.2 South America Antitussive Drugs Market Size by Country
- 10.2.1 South America Antitussive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Antitussive Drugs Market Size by Country (2021-2026)
- 10.2.3 South America Antitussive Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Antitussive Drugs Sales by Country
- 11.1.1 Middle East and Africa Antitussive Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Antitussive Drugs Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Antitussive Drugs Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Antitussive Drugs Market Size by Country
- 11.2.1 Middle East and Africa Antitussive Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Antitussive Drugs Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Antitussive Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Antitussive Drugs Value Chain Analysis
- 12.1.1 Antitussive Drugs Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Antitussive Drugs Production Mode & Process
- 12.2 Antitussive Drugs Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Antitussive Drugs Distributors
- 12.2.3 Antitussive Drugs Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst